Impact Data - Emergency Contraception Promotion Project (ECPP)
- Provider knowledge increased significantly from pretest to posttest regarding the effectiveness of ECPs (51% to 85%), safety of ECPs (40% to 75%), and the timing of the first dose (34% to 59%).
- Provider knowledge increased significantly from pretest to posttest regarding how ECPs work and common side effects:
- how ECPs appear to work: delaying ovulation increased from 12% to 22%, preventing fertilisation increased from 17% to 36%, and preventing implantation increased from 56% to 80%
- knowledge of nausea and vomiting as side effects increased from 51% to 75% and 29% to 45%, respectively
- ECPs do not act by causing an abortion - increased from 78% to 96%
- Providing EC information/pills does not discourage consistent use of other contraceptive methods - increased from 76% to 88%
- Unprotected intercourse would not increase if ECPs were available to all women - increased from 70% to 84%
- Repeated use of ECPs does not pose health risks - increased from 46% to 65%
- ECPs should be available over-the-counter without a prescription - increased from 42% to 54%
There was an increase in the number of non-clinical trainees reporting that they talk about EC. Those who sometimes (less than 2 times a week) talk about EC with their clients increased from 30% at the pretest to 52% at posttest; those who talk 3 or more times a week about EC with clients increased from 5% at the pretest to 18% at posttest.
- Log in to post comments












































